Pharma news
Americas
LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California. 21 October 2025
Americas
The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment. 20 October 2025
Europe
The court rejected Novartis’s request for emergency measures against a Spanish importer after the pharma company failed to meet the test to enforce an injunction, the winning lawyers told LSIPR. 16 October 2025
Pharma
After saving hundreds of thousands of dollars ‘with my laptop and ChatGPT’, the biotech’s trademarks leader says lawyers need to discover how the tech can reduce external spend. 16 October 2025
Europe
As Big Pharma stalls investment in the UK, the government urgently needs to return to the negotiating table to salvage a key growth area, writes Tim Belcher of EIP. 14 October 2025
Americas
A recent survey shows heavy opposition to the proposal which could leave university licensing struggling, chill investment in startups, and threaten technology transfers. 13 October 2025
Pharma
A new report highlights widespread mental health issues among legal professionals, leading to poor wellbeing and career disillusionment. 10 October 2025
Americas
The pharma giant extends market exclusivity for a top-selling drug accounting for nearly half of its multi-billion-dollar sales. 9 October 2025
Europe
The promises and pitfalls of AI took centre stage at CIPA’s annual congress in Bristol this week, as Sarah Speight reports. 9 October 2025
Americas
A 2021 Supreme Court ruling changed how patent terms are calculated, forcing pharma companies to rethink their IP strategies. Juliana Neves of Licks explains the key changes, upcoming reforms, and how companies can protect their portfolios effectively. 8 October 2025